Literature DB >> 21417589

iNOS-derived nitric oxide stimulates osteoclast activity and alveolar bone loss in ligature-induced periodontitis in rats.

Bruno S Herrera1, Rodrigo Martins-Porto, Aline Maia-Dantas, Paula Campi, Luis C Spolidorio, Soraia K P Costa, Thomas E Van Dyke, Robert Gyurko, Marcelo N Muscara.   

Abstract

BACKGROUND: Inflammatory stimuli activate inducible nitric oxide synthase (iNOS) in a variety of cell types, including osteoclasts (OC) and osteoblasts, resulting in sustained NO production. In this study, we evaluate the alveolar bone loss in rats with periodontitis under long-term iNOS inhibition, and the differentiation and activity of OC from iNOS-knockout (KO) mice in vitro.
METHODS: Oral aminoguanidine (an iNOS inhibitor) or water treatment was started 2 weeks before induction of periodontitis. Rats were sacrificed 3, 7, or 14 days after ligature placement, and alveolar bone loss was evaluated. In vitro OC culture experiments were also performed to study the differentiation of freshly isolated bone marrow cells from both iNOS KO and wild-type C57BL/6 mice. OC were counted 6 days later after tartrate-resistant acid phosphatase staining (a marker of osteoclast identity), and bone resorption activity was assessed by counting the number of resorption pits on dentin disks.
RESULTS: Rats with ligature showed progressive and significant alveolar bone loss compared to sham animals, and aminoguanidine treatment significantly inhibited ligature-induced bone loss at 7 and 14 days after the induction. In comparison to bone marrow cells from wild-type mice, cells from iNOS KO mice showed decreased OC growth and the resulting OC covered a smaller culture dish area and generated fewer resorption pit counts.
CONCLUSION: Our results demonstrate that iNOS inhibition prevents alveolar bone loss in a rat model of ligature-induced periodontitis, thus confirming that iNOS-derived NO plays a crucial role in the pathogenesis of periodontitis, probably by stimulating OC differentiation and activity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21417589      PMCID: PMC3361509          DOI: 10.1902/jop.2011.100768

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  52 in total

Review 1.  Osteoimmunology: interactions of the bone and immune system.

Authors:  Joseph Lorenzo; Mark Horowitz; Yongwon Choi
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

2.  Nitric oxide is a regulator of bone remodelling.

Authors:  H J Chae; R K Park; H T Chung; J S Kang; M S Kim; D Y Choi; B G Bang; H R Kim
Journal:  J Pharm Pharmacol       Date:  1997-09       Impact factor: 3.765

3.  Deficiency of iNOS contributes to Porphyromonas gingivalis-induced tissue damage.

Authors:  J Alayan; S Ivanovski; E Gemmell; P Ford; S Hamlet; C S Farah
Journal:  Oral Microbiol Immunol       Date:  2006-12

4.  Inducible nitric oxide synthase mediates bone development and P. gingivalis-induced alveolar bone loss.

Authors:  R Gyurko; H Shoji; R A Battaglino; G Boustany; F C Gibson; C A Genco; P Stashenko; T E Van Dyke
Journal:  Bone       Date:  2005-03       Impact factor: 4.398

5.  Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity.

Authors:  R J van't Hof; S H Ralston
Journal:  J Bone Miner Res       Date:  1997-11       Impact factor: 6.741

6.  Nitric oxide synthase inhibition prevents alveolar bone resorption in experimental periodontitis in rats.

Authors:  R F C Leitão; R A Ribeiro; H V Chaves; F A C Rocha; V Lima; G A C Brito
Journal:  J Periodontol       Date:  2005-06       Impact factor: 6.993

7.  Intermittent use of nitrates increases bone mineral density: the study of osteoporotic fractures.

Authors:  S A Jamal; W S Browner; D C Bauer; S R Cummings
Journal:  J Bone Miner Res       Date:  1998-11       Impact factor: 6.741

8.  Inhibition of nitric oxide synthase blocks osteoclastic bone resorption in adaptive bone modeling.

Authors:  R A Chole; S P Tinling; E Leverentz; M D McGinn
Journal:  Acta Otolaryngol       Date:  1998-09       Impact factor: 1.494

9.  Genetic disruption of all NO synthase isoforms enhances BMD and bone turnover in mice in vivo: involvement of the renin-angiotensin system.

Authors:  Ken Sabanai; Masato Tsutsui; Akinori Sakai; Hideyuki Hirasawa; Shinya Tanaka; Eiichiro Nakamura; Akihide Tanimoto; Yasuyuki Sasaguri; Masako Ito; Hiroaki Shimokawa; Toshitaka Nakamura; Nobuyuki Yanagihara
Journal:  J Bone Miner Res       Date:  2008-05       Impact factor: 6.741

10.  Morphologic evaluation and expression of matrix metalloproteinases-2 and 9 and nitric oxide during experimental periodontal disease in rat.

Authors:  Camila Oliveira Rodini; Aline Carvalho Batista; Thiago José Dionísio; Carlos Ferreira Santos; Fernando Queiroz Cunha; Vanessa Soares Lara
Journal:  J Mol Histol       Date:  2008-02-05       Impact factor: 2.611

View more
  16 in total

1.  microRNA Expression in Rat Apical Periodontitis Bone Lesion.

Authors:  Bo Gao; Liwei Zheng
Journal:  Bone Res       Date:  2013-06-28       Impact factor: 13.567

2.  The Porphyromonas gingivalis Hybrid Cluster Protein Hcp Is Required for Growth with Nitrite and Survival with Host Cells.

Authors:  B Ross Belvin; Qin Gui; Justin A Hutcherson; Janina P Lewis
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

3.  NADPH Oxidase Contributes to Resistance against Aggregatibacter actinomycetemcomitans-Induced Periodontitis in Mice.

Authors:  Antje Bast; Helen Kubis; Birte Holtfreter; Silvia Ribback; Heiner Martin; Helen C Schreiner; Malte J Dominik; Katrin Breitbach; Frank Dombrowski; Thomas Kocher; Ivo Steinmetz
Journal:  Infect Immun       Date:  2017-01-26       Impact factor: 3.441

4.  Topical treatment with probiotic Lactobacillus brevis CD2 inhibits experimental periodontal inflammation and bone loss.

Authors:  T Maekawa; G Hajishengallis
Journal:  J Periodontal Res       Date:  2014-02-01       Impact factor: 4.419

5.  [Effects of periodontitis patient's own tissue nucleic acid on the mRNA expression of osteoclast-related factors in murine macrophages].

Authors:  Ding Ziqing; Shen Yuqin; Zhou Yue; Lin Yin; Gao Han; Yu Haijiao; Lin Chongtao
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2015-04

6.  R848, a toll-like receptor 7 agonist, inhibits osteoclast differentiation but not survival or bone-resorbing function of mature osteoclasts.

Authors:  Arei Miyamoto; Masamichi Takami; Akifumi Matsumoto; Ayako Mochizuki; Takako Yamada; Keita Tachi; Isao Shibuya; Tomoya Nakamachi; Seiji Shioda; Kazuyoshi Baba; Tomio Inoue; Yoichi Miyamoto; Mijung Yim; Ryutaro Kamijo
Journal:  Cytotechnology       Date:  2012-02-23       Impact factor: 2.058

Review 7.  Metformin for Cardiovascular Protection, Inflammatory Bowel Disease, Osteoporosis, Periodontitis, Polycystic Ovarian Syndrome, Neurodegeneration, Cancer, Inflammation and Senescence: What Is Next?

Authors:  Moein Ala; Mahan Ala
Journal:  ACS Pharmacol Transl Sci       Date:  2021-11-01

8.  Myeloid-derived suppressor cells function as novel osteoclast progenitors enhancing bone loss in breast cancer.

Authors:  Anandi Sawant; Jessy Deshane; Joel Jules; Carnella M Lee; Brittney A Harris; Xu Feng; Selvarangan Ponnazhagan
Journal:  Cancer Res       Date:  2012-12-14       Impact factor: 12.701

9.  Treatment with hydrogen molecules prevents RANKL-induced osteoclast differentiation associated with inhibition of ROS formation and inactivation of MAPK, AKT and NF-kappa B pathways in murine RAW264.7 cells.

Authors:  Dong-Zhu Li; Qing-Xiang Zhang; Xiao-Xian Dong; Huai-Dong Li; Xin Ma
Journal:  J Bone Miner Metab       Date:  2013-11-07       Impact factor: 2.626

10.  Xylitol, an anticaries agent, exhibits potent inhibition of inflammatory responses in human THP-1-derived macrophages infected with Porphyromonas gingivalis.

Authors:  Eunjoo Park; Hee Sam Na; Sheon Min Kim; Shannon Wallet; Seunghee Cha; Jin Chung
Journal:  J Periodontol       Date:  2014-03-04       Impact factor: 6.993

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.